Combined inhibition of Stat3 and HIF-1α for enhancement of radio- and chemo-sensitivity in laryngeal squamous cell carcinoma.
- Author:
Yajing SUN
;
Xiuying LU
;
Xiaoming LI
- Publication Type:Journal Article
- MeSH:
Blotting, Western;
Carcinoma, Squamous Cell;
Cell Hypoxia;
Cell Line, Tumor;
Humans;
Hypoxia;
Hypoxia-Inducible Factor 1, alpha Subunit;
Laryngeal Neoplasms;
STAT3 Transcription Factor
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2015;29(4):352-356
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the influence of signal transducer and activator of transcription 3 (Stat3) and hypoxia-inducible factor-lα (HIF-1α) on the resistance effect of laryngeal squamous cell carcinoma to radiation therapy and chemotherapy under the hypoxia circumstances.
METHOD:Western blot was used to test the expression of p-Stat3 and HIF-1α in the Hep-2 cells under the hypoxia conditions. MTT assay was used to test the proliferation of Hep-2 cells after radiation therapy and chemotherapy; the Hep-2 cells were suppressed expression of Stat3 and/or HIF-1α.
RESULT:(1) AG490 induced significant proliferation inhibition on Hep-2 cells and Hep-2HIF-1α-/- cells in vitro underthe hypoxia environments (P < 0.05); (2) Suppressing expression of Stat3 reduced the expression of HIF-1α protein (P < 0.05); (3) Combined inhibition of Stat3 and HIF-1α enhanced radio- and chemo-sensitivity in laryngeal squamous carcinoma cells under hypoxia.
CONCLUSION:Combined inhibition of Stat3 and HIF-1α can further enhance radio- and chemo-sensitivity in laryngeal squamous carcinoma cells under hypixia compare than inhibiting Stat3 or HIF-1α alone. Effectively blocking of HIF-1α pathway and suppressing the expression of Stat3, would be an effective method to enhance radio- and chemo-sensitivity in laryngeal squamous carcinoma cells, which provides a new thought to reduce the resistance to treatment.
